宋国磊, 郭涵, 时依, 刘牧林, 姜从桥. 生物反馈疗法在低位直肠前切除综合征中的应用研究[J]. 蚌埠医科大学学报, 2023, 48(7): 901-905. DOI: 10.13898/j.cnki.issn.1000-2200.2023.07.010
    引用本文: 宋国磊, 郭涵, 时依, 刘牧林, 姜从桥. 生物反馈疗法在低位直肠前切除综合征中的应用研究[J]. 蚌埠医科大学学报, 2023, 48(7): 901-905. DOI: 10.13898/j.cnki.issn.1000-2200.2023.07.010
    SONG Guo-lei, GUO Han, SHI Yi, LIU Mu-lin, JIANG Cong-qiao. Application of biofeedback therapy in low anterior rectum resection syndrome[J]. Journal of Bengbu Medical University, 2023, 48(7): 901-905. DOI: 10.13898/j.cnki.issn.1000-2200.2023.07.010
    Citation: SONG Guo-lei, GUO Han, SHI Yi, LIU Mu-lin, JIANG Cong-qiao. Application of biofeedback therapy in low anterior rectum resection syndrome[J]. Journal of Bengbu Medical University, 2023, 48(7): 901-905. DOI: 10.13898/j.cnki.issn.1000-2200.2023.07.010

    生物反馈疗法在低位直肠前切除综合征中的应用研究

    Application of biofeedback therapy in low anterior rectum resection syndrome

    • 摘要:
      目的探讨生物反馈疗法(BFT)在低位直肠前切除综合征(LARS)中的临床疗效。
      方法回顾性分析腹腔镜低位直肠前切除术后符合LARS诊断标准的165例病人资料,根据LARS处理方式的不同分为BFT组86例和对照组79例。BFT组自出院后第3周起规律行2个疗程BFT,对照病人术后常规对症治疗。比较2组病人治疗前后LARS量表评分变化。
      结果入组时和第一疗程结束后,2组病人LARS量表评分差异均无统计学意义(P>0.05)。第二疗程结束后,2组病人评分均较入组时降低(P < 0.05),且BFT组评分明显低于对照组(P < 0.01)。第二疗程结束后2周,2组评分均较入组时和第一、二疗程结束后降低(P < 0.05),且BFT组明显低于对照组(P < 0.01)。
      结论BFT较常规治疗能更快地降低病人术后LARS量表评分,加快LARS病人的恢复。

       

      Abstract:
      ObjectiveTo investigate the clinical effect of biofeedback therapy (BFT) in low anterior rectal resection syndrome(LARS).
      MethodsThe data of 165 patients who met the diagnostic criteria of LARS after laparoscopic low anterior rectal resection were analyzed retrospectively.According to the different treatment methods of LARS, they were divided into BFT group(86 cases) and control group(79 cases).The BFT group received two courses of BFT regularly from the 3rd week after discharge, and the control group received routine symptomatic treatment after operation.The changes of LARS scores before and after treatment were compared between the two groups.
      ResultsThere was no significant difference in LARS scores between the two groups at the time of enrollment and after the first course of treatment(P>0.05).After the second course of treatment, the scores of patients in the two groups were lower than those at the time of enrollment(P < 0.05), and the scores in the BFT group were significantly lower than those in the control group(P < 0.01).Two weeks after the end of the second course of treatment, the scores in the two groups were lower than those at the end of first and second courses of treatment(P < 0.05), and the scores in the BFT group were significantly lower than that in the control group(P < 0.01).
      ConclusionsBFT can reduce the LARS scores faster than conventional treatment, and accelerate the recovery of LARS patients.

       

    /

    返回文章
    返回